BlackRock Fund Advisors’s THERAGENICS CORP TGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-95,309
Closed -$208K 3897
2013
Q3
$208K Buy
95,309
+7,488
+9% +$16K ﹤0.01% 3376
2013
Q2
$182K Buy
+87,821
New +$157K ﹤0.01% 3356

BlackRock Fund Advisors's TGX Position: Q4 2013 in Review

BlackRock Fund Advisors sold out of THERAGENICS CORP (TGX) in Q4 2013, closing a stake of 95,309 shares — an estimated $208K sold.

BlackRock Fund Advisors first reported a position in TGX in Q2 2013 and held it in 2 quarters. The position peaked at $208K in Q3 2013. 0 funds tracked by Wall St. Rank hold TGX as of Q4 2013.

  • BlackRock Fund Advisors reported no remaining THERAGENICS CORP position as of Q4 2013 after selling out during the quarter.
  • BlackRock Fund Advisors sold 95,309 THERAGENICS CORP shares in Q4 2013, an estimated $208K.
  • BlackRock Fund Advisors first reported a position in THERAGENICS CORP in Q2 2013 and held it in 2 quarters.
  • BlackRock Fund Advisors's THERAGENICS CORP position peaked at $208K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q4 2013.

Based on BlackRock Fund Advisors's 13F filing for Q4 2013, filed 12 Feb 2014.